← Leaderboards
Matthew Thomas Allemang
Cleveland Clinic Lerner Com-Cwru
$1,044,209
Attributed
$1,044,209
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $271.5K · FY2021–24$500K$375K$250K$125K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$1,044,209 · 1
By mechanism
R01$1,044,209 · 1
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- John Rodriguez$251,098
Research focus
Fatty Acid Glycerol EstersEtiologyAnatomyBolus InfusionAlbuminsChronicClinical TrialsColloidsConsumptionDeveloped CountriesDevicesDiabetes MellitusDiabeticDiet ModificationDiscipline Of Nuclear MedicineDouble-Blind MethodEarly SatietyEfficacy EvaluationEgg WhiteElectric StimulationElectric Stimulation TherapyEndoscopyEpidemicFood
Grant awards (4)
Per-Oral Pyloromyotomy (POP) in the treatment of medical refractory gastroparesis : A randomized, sham-controlled trial$270,480
R01 · FY2024 · DK · contact PI
Per-Oral Pyloromyotomy (POP) in the treatment of medical refractory gastroparesis : A randomized, sham-controlled trial$271,533
R01 · FY2023 · DK · contact PI
Per-Oral Pyloromyotomy (POP) in the treatment of medical refractory gastroparesis : A randomized, sham-controlled trial$251,098
R01 · FY2022 · DK · contact PI
Per-Oral Pyloromyotomy (POP) in the treatment of medical refractory gastroparesis : A randomized, sham-controlled trial$251,098
R01 · FY2021 · DK · contact PI